Blood pressure control and cardiovascular risk profile in hypertensive patients under specialist care in Argentina: Results from the CHARTER study.


Journal

Journal of clinical hypertension (Greenwich, Conn.)
ISSN: 1751-7176
Titre abrégé: J Clin Hypertens (Greenwich)
Pays: United States
ID NLM: 100888554

Informations de publication

Date de publication:
10 2019
Historique:
received: 14 06 2019
revised: 23 07 2019
accepted: 02 08 2019
pubmed: 4 9 2019
medline: 22 10 2020
entrez: 4 9 2019
Statut: ppublish

Résumé

Worldwide, hypertension control rate is far from ideal. Some studies suggest that patients treated by specialists have a greater chance to achieve control. The authors aimed to determine the BP control rate among treated hypertensive patients under specialist care in Argentina, to characterize patients regarding their cardiovascular risk profile and antihypertensive drug use, and to assess the variables independently associated with adequate BP control. The authors included adult hypertensive patients under stable treatment, managed in 10 specialist centers across Argentina. Office BP was measured thrice with a validated oscillometric device. Adequate BP control was defined as an average of the three readings <140/90 mm Hg (and <150/90 in patients older than 80 years). The authors estimated the proportion of adequate BP control and the variables independently associated with it through a multiple conditional logistic regression model. Among the 1146 included patients, 48.2% were men with a mean age of 63.5 (±13.1) years old. Mean office BP was 135.3 (±14.8)/80.8 (±10) mm Hg, with a 64.8% (95% CI: 62%-67.6%) of adequate control. The mean number of antihypertensive drugs was 2.1 per participant, the commonest being angiotensin receptor blockers and calcium channel blockers. In multivariable analysis, only female sex was a predictor of adequate BP control (OR 1.33 [95% CI 1.02-1.72], P = .04). In conclusion, almost 65% of hypertensive patients treated in specialist centers in Argentina have adequate BP control. The challenge for future research is to define strategies in order to translate this control rate to the primary care level, where most patients are managed.

Identifiants

pubmed: 31479195
doi: 10.1111/jch.13684
pmc: PMC8030316
doi:

Substances chimiques

Angiotensin Receptor Antagonists 0
Antihypertensive Agents 0
Calcium Channel Blockers 0

Types de publication

Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

1456-1462

Informations de copyright

©2019 Wiley Periodicals, Inc.

Références

J Clin Hypertens (Greenwich). 2019 Oct;21(10):1456-1462
pubmed: 31479195
Circ Res. 2015 Mar 13;116(6):925-36
pubmed: 25767281
Clin Exp Hypertens. 2017;39(3):264-270
pubmed: 28448187
Circulation. 2018 Oct 23;138(17):e426-e483
pubmed: 30354655
Am J Hypertens. 2004 Feb;17(2):112-7
pubmed: 14751651
Curr Hypertens Rep. 2017 Oct 25;19(12):94
pubmed: 29071520
Am J Cardiol. 2003 Jul 3;92(1A):19i-26i
pubmed: 12867251
J Hum Hypertens. 2015 Nov;29(11):696-701
pubmed: 25673112
Rev Med Chil. 2014 Oct;142(10):1245-52
pubmed: 25601108
Hypertens Res. 2011 Apr;34(4):423-30
pubmed: 21228778
Arch Intern Med. 2002 Mar 11;162(5):582-6
pubmed: 11871927
J Hypertens. 2018 Oct;36(10):1953-2041
pubmed: 30234752
J Clin Hypertens (Greenwich). 2018 Dec;20(12):1686-1695
pubmed: 30444315
Hypertension. 2008 Jan;51(1):55-61
pubmed: 18039980
J Hypertens. 2014 Jan;32(1):3-15
pubmed: 24270181
J Hypertens. 2019 Feb;37(2):398-405
pubmed: 30074565
Eur Heart J. 2011 Jan;32(2):218-25
pubmed: 21047877
Hipertens Riesgo Vasc. 2019 Apr - Jun;36(2):96-109
pubmed: 30824233
Circulation. 2005 Apr 12;111(14):1777-83
pubmed: 15809377
Lancet. 2012 Aug 11;380(9841):611-9
pubmed: 22883510
Lancet. 2012 Dec 15;380(9859):2224-60
pubmed: 23245609
Clin Ther. 2004 Aug;26(8):1292-304
pubmed: 15476910
Ter Arkh. 2018 Feb 14;90(1):17-21
pubmed: 30701752
J Hypertens. 2004 Dec;22(12):2387-96
pubmed: 15614034
Hypertens Res. 2015 Aug;38(8):570-5
pubmed: 25832917
Korean Circ J. 2018 Jul;48(7):552-564
pubmed: 29968429

Auteurs

Marcos Marín (M)

Argentinian Society of Hypertension, Buenos Aires, Argentina.
Hospital Italiano Ctro. Agustín Rocca-San Justo (HICAR), Buenos Aires, Argentina.

Jessica Barochiner (J)

Argentinian Society of Hypertension, Buenos Aires, Argentina.
Hospital Italiano de Buenos Aires, Buenos Aires, Argentina.

Pablo Rodríguez (P)

Argentinian Society of Hypertension, Buenos Aires, Argentina.
Sanatorio Municipal Dr. Julio Méndez, Buenos Aires, Argentina.

Nicolás Renna (N)

Argentinian Society of Hypertension, Buenos Aires, Argentina.
Hospital Español de Mendoza, Mendoza, Argentina.

Carlos Castellaro (C)

Argentinian Society of Hypertension, Buenos Aires, Argentina.
Centro de educación médica e investigaciones clínicas "Norberto Quirno" (CEMIC), Buenos Aires, Argentina.

Walter Espeche (W)

Argentinian Society of Hypertension, Buenos Aires, Argentina.
Hospital San Martín, Buenos Aires, Argentina.

Alejandro De Cerchio (A)

Argentinian Society of Hypertension, Buenos Aires, Argentina.
Instituto de Cardiología de Corrientes "Juana Francisca Cabral", Corrientes, Argentina.

Mildren Del Sueldo (M)

Argentinian Society of Hypertension, Buenos Aires, Argentina.
Fundación Certus - Clínica de Especialidades, Córdoba, Argentina.

Sergio Vissani (S)

Argentinian Society of Hypertension, Buenos Aires, Argentina.
Centro de neurología y rehabilitación-CENYR, San Luis, Argentina.

Judith Zilberman (J)

Argentinian Society of Hypertension, Buenos Aires, Argentina.
Hospital General de Agudos "Dr. Cosme Argerich", Buenos Aires, Argentina.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH